GDIs block activation of RHOG

Stable Identifier
R-HSA-9014456
Type
Reaction [binding]
Species
Homo sapiens
Compartment
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
The following GDP dissociation inhibitors (GDIs) bind to RHOG and inhibit its activation:
ARHGDIA (Elfenbein et al. 2009)
ARHGDIB (Vignal et al. 2001)
ARHGDIG (Zalcman et al. 1996; Brunet et al. 2002)
Literature References
PubMed ID Title Journal Year
11689693 Kinectin is a key effector of RhoG microtubule-dependent cellular activity

Blangy, A, Gauthier-Rouvière, C, Vignal, E, Martin, M, Fort, P

Mol. Cell. Biol. 2001
11967128 RhoGDI-3 regulates RhoG and targets this protein to the Golgi complex through its unique N-terminal domain

Morin, A, Brunet, N, Olofsson, B

Traffic 2002
19581409 Suppression of RhoG activity is mediated by a syndecan 4-synectin-RhoGDI1 complex and is reversed by PKCalpha in a Rac1 activation pathway

Matsuda, M, Rhodes, JM, Meller, J, Simons, M, Elfenbein, A, Schwartz, MA

J. Cell Biol. 2009
8939998 RhoGDI-3 is a new GDP dissociation inhibitor (GDI). Identification of a non-cytosolic GDI protein interacting with the small GTP-binding proteins RhoB and RhoG

Honoré, N, Olofsson, B, Camonis, J, Rousseau-Merck, MF, Zalcman, G, Closson, V, Tavitian, A

J. Biol. Chem. 1996
Participants
Participates
Orthologous Events
Authored
Reviewed
Created
Cite Us!